Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29942
Title: | Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with a suboptimal response to previous disease-modifying therapies (1-year interim results) | Authors: | Vermersch, P. Eralinna, J. -P. Nicholas, R. Oreja-Guevara, C. Siva, A. VAN WIJMEERSCH, Bart Wiendl, H. Buffels, R. Kuhelj, R. Wei, W. Comi, G. |
Issue Date: | 2019 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 25(SI), p. 344-345 (Art N° P690) | Notes: | [Vermersch, P.] Univ Lille, Lille, France. [Eralinna, J. -P.] NEO Res, Turku, Finland. [Nicholas, R.] Imperial Coll Healthcare NHS Trust, London, England. [Nicholas, R.] Imperial Coll, London, England. [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. [Siva, A.] Istanbul Univ, Cerrahpasa Sch Med, Cerrahpasa, Turkey. [Van Wijmeersch, B.] Univ Hasselt, Overpelt, Belgium. [Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Overpelt, Belgium. [Wiendl, H.] Univ Munster, Munster, Germany. [Buffels, R.; Kuhelj, R.; Wei, W.] F Hoffmann La Roche Ltd, Basel, Switzerland. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. | Keywords: | Clinical Neurology; Neurosciences | Document URI: | http://hdl.handle.net/1942/29942 | ISSN: | 1352-4585 | e-ISSN: | 1477-0970 | ISI #: | 000485303101246 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Show full item record
WEB OF SCIENCETM
Citations
1
checked on Oct 14, 2024
Page view(s)
76
checked on Jul 31, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.